Geneva, May 28 -- International Clinical Trials Registry received information related to the study (ACTRN12625000401459) titled 'Pilot study of medication repurposing for idiopathic intracranial hypertension' on May 2.
Study Type: Interventional
Study Design:
Purpose: Treatment
Allocation: Randomised controlled trial
Masking: Blinded (masking used)
Assignment: Parallel
Primary Sponsor: Alfred Hospital
Condition:
Idiopathic intracranial hypertension
Idiopathic intracranial hypertension
Neurological - Other neurological disorders
Intervention:
Empagliflozin 25mg daily for 12 weeks administered as an oral tablet.
Adherence will be monitored based on drug tablet return....
Recruitment Status: Not Recruiting
Phase: Phase 2
Date o...